|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/22/2024 |
$51.65 |
$52.45 |
$51.52 |
$51.93 |
11.73M | 03/25/2024 |
$52.08 |
$52.74 |
$51.91 |
$52.25 |
12.35M | 03/26/2024 |
$52.39 |
$52.65 |
$52.04 |
$52.55 |
9.95M | 03/27/2024 |
$53.00 |
$53.69 |
$52.85 |
$53.25 |
13.08M | 03/28/2024 |
$53.39 |
$54.48 |
$53.39 |
$54.23 |
14.35M |
|
Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Co.'s pharmaceutical products include chemically-synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric antigen receptor T-cell therapies. Co.'s primary product includes Eliquis® - Eliquis (apixaban), which is an oral Factor Xa inhibitor indicated for the reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE and reduction in risk of recurrence following initial therapy. | |
|
Bristol Myers Squibb (BMY) has the following price history information. Looking back at BMY historical stock prices for the last five trading days, on March 22, 2024, BMY opened at $51.65, traded as high as $52.45 and as low as $51.52, and closed at $51.93. Trading volume was a total of 11.73M shares. On March 25, 2024, BMY opened at $52.08, traded as high as $52.74 and as low as $51.91, and closed at $52.25. Trading volume was a total of 12.35M shares. On March 26, 2024, BMY opened at $52.39, traded as high as $52.65 and as low as $52.04, and closed at $52.55. Trading volume was a total of 9.95M shares. On March 27, 2024, BMY opened at $53.00, traded as high as $53.69 and as low as $52.85, and closed at $53.25. Trading volume was a total of 13.08M shares. On March 28, 2024, BMY opened at $53.39, traded as high as $54.48 and as low as $53.39, and closed at $54.23. Trading volume was a total of 14.35M shares.
BMY Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Bristol Myers Squibb shares, starting with a $10,000 purchase of BMY, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
Start date: |
04/01/2014 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$51.87 |
|
End price/share: |
$54.23 |
|
Starting shares: |
192.79 |
|
Ending shares: |
259.04 |
|
Dividends reinvested/share: |
$17.68 |
|
Total return: |
40.48% |
|
Average Annual Total Return: |
3.46% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$14,050.26 |
|
Years: |
10.00 |
|
|
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/01/2014 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$51.87 |
|
End price/share: |
$54.23 |
|
Dividends collected/share: |
$17.68 |
|
Total return: |
38.64% |
|
Average Annual Total Return: |
3.32% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$13,861.34 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
03/22/2024 | $51.93 | 03/25/2024 | $52.25 | 03/26/2024 | $52.55 | 03/27/2024 | $53.25 | 03/28/2024 | $54.23 |
|
|